Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:02 AM
Study NCT ID:
NCT03886220
Status:
COMPLETED
Last Update Posted:
2022-03-31
First Post:
2019-03-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-28
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-20
First Submit QC Date:
None
Study First Post Date:
2019-03-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-03-04
Results First Submit QC Date:
None
Results First Post Date:
2022-03-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-04
Last Update Post Date:
2022-03-31
Last Update Post Date Type:
ACTUAL